Dopamine transporter loss and clinical changes in MPTP-lesioned primates
- 17 June 1999
- journal article
- Published by Elsevier in Brain Research
- Vol. 832 (1-2) , 184-187
- https://doi.org/10.1016/s0006-8993(99)01491-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changesBrain Research, 1998
- 6-[18F]Fluoro-l-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primatesBrain Research, 1997
- SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primatesSynapse, 1993
- Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI‐55Synapse, 1992
- Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatumSynapse, 1991
- Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CITEuropean Journal of Pharmacology, 1991
- [125I]RTI-55: a potent ligand for dopamine transportersEuropean Journal of Pharmacology, 1991
- High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissueBrain Research, 1989
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986